Blood-Based ScoresReferral / Risk Stratification
Laboratory-Based Biomarkers • Blood-Based Scores

Steatosis–Associated Fibrosis Estimator (SAFE) Score

Nonproprietary primary-care score designed to detect clinically significant liver fibrosis (>=F2) using routine clinical and metabolic parameters.

What This Means for Patients

While FIB-4 was originally built to catch advanced scarring (F3–F4), the newer SAFE score was specifically designed in MASLD populations to catch moderate-or-worse scarring (F2 and above) earlier in primary care. A SAFE score below 0 helps rule out clinically significant fibrosis, while a score of 100 or higher makes F2+ scarring likely and supports specialist evaluation.

What Is the SAFE Score?

  • A nonproprietary score combining 7 routine clinical and laboratory inputs (age, BMI, diabetes status, AST, ALT, platelet count, and globulins [total protein minus albumin])1
  • Estimates the likelihood of clinically significant liver fibrosis (≥F2) in patients with suspected liver disease1,2

Use in MASLD/MASH Care

  • Supports risk stratification in primary care settings, helping determine which patients can be safely monitored in primary care and which warrant referral to specialist care1

How Is It Measured?

SAFE = (2.97 × age) + (5.99 × BMI [BMI >40 is set to 40])
+ (62.85 × diabetes [0 if absent, 1 if present])
+ (154.85 × Ln(AST)) – (58.23 × Ln(ALT))
+ (195.48 × Ln(globulins, g/dL))
– (141.61 × Ln(platelets, 109/L)) – 75
  • It is calculated using the following formula available online1

Strengths

  • The SAFE score can predict fibrosis across all patient groups regardless of race/ethnicity or diabetes status2

Limitations

  • Unclear diagnostic performance in populations with low BMI (<25 kg/m2) or Asian populations due to limited data1

Interactive SAFE Score Calculator (≥F2 Fibrosis Screen)

100% Private • Runs in Browser

Computes the logarithmic 7-variable SAFE formula (Sripongpun et al., Hepatology 2023). Tip: if your CMP does not print Globulin directly, subtract Albumin from Total Protein (e.g. Total Protein 7.1 − Albumin 4.3 = 2.8 g/dL).

Published Cutoff Values for Fibrosis Staging Using the SAFE Score1,3

Clinical Tier SAFE Score Sensitivity,a % Specificity,b %
Low Risk (Rule out ≥F2) <0 77 58
Intermediate Risk (Proceed to VCTE or ELF™) 0 to <100 Indeterminate zone — confirm fibrosis stage with second-line elastography or serum NIT1
High Risk (Rule in ≥F2) ≥100 43 88